Marked expression of plasma brain natriuretic peptide is a special feature of hypertrophic obstructive cardiomyopathy

Journal of the American College of Cardiology

Volumn 28, Issue 5, 1996, Pages 1234-1242

  Nishigaki, Kazuhiko ^a   Tomita, Masaaki ^a   Kagawa, Kensaku ^a   Noda, Toshiyuki ^a   Minatoguchi, Shinya ^a   Oda, Hiroshi ^b   Watanabe, Sachiro ^b   Morita, Norihiko ^c   Nakao, Kazuwa ^d   Fujiwara, Hisayoshi ^a,e  

^a GIFU UNIVERSITY   (Japan)

^b GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

^c Matsunami General Hospital   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; AORTA STENOSIS; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEMODYNAMICS; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; MALE; PRIORITY JOURNAL;

ADULT; AGED; AORTIC VALVE STENOSIS; ATRIAL NATRIURETIC FACTOR; BRAIN-DERIVED NEUROTROPHIC FACTOR; CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION;

EID: 0030298102     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00277-X     Document Type: Article

References (27)

1. 1. Hirota Y, Furubayashi K, Kaku K, et al. Hypertrophic nonobstructive cardiomyopathy: a precise assessment of hemodynamic characteristics and clinical implications. Am J Cardiol 1982;50:990-7.
2. 2. Gilbert BW, Pollick C, Adelman AG, Wigle ED, Hypertrophic cardiomyopathy: subclassification by M mode echocardiography. Am J Cardiol 1980;45: 861-72.
3. 3. Ciro E, Maron BJ, Bonow RO, Cannon RO, Epstein SE. Relation between marked changes in left ventricular outflow tract gradient and disease progression in hypertrophic cardiomyopathy. Am J Cardiol 1984;53:1103-9.
4. 4. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988;332:78-81.
5. 5. Kambayashi Y, Nakao K, Mukoyama M, et al. Isolation and sequence determination of human brain natriuretic peptide in human atrium, FEBS Lett 1990;259:341-5.
6. 6. Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans - evidence for an exquisite dual natriuretic peptide system, atrial peptide and brain natriuretic peptide. J Clin Invest 1991;87:1402-12.
7. 7. Lang CC, Choy AMJ, Struthers AD. Atrial and brain natriuretic peptides: a dual natriuretic peptide system potentially involved in circulatory homeostasis. Clin Sci 1992;83:519-27.
8. 8. Hosoda K, Nakao K, Mukoyama M, et al. Expression of brain natriuretic peptide gene in human heart: production in the ventricle. Hypertension 1991;17:1152-6.
9. 9. Ogawa Y, Nakao K, Mukoyama M, et al. Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats - the ventricles are a major site of synthesis and secretion of brain natriuretic peptide. Circ Res 1991;69:491-500.
10. 10. Hasegawa K, Fujiwara H, Doyama K, et al. Ventricular expression of atrial and brain natriuretic peptides in dilated cardiomyopathy: an immunohistochemical study of the endomyocardial biopsy specimens using specific monoclonal antibodies. Am J Pathol 1993;142:107-16.
11. 11. Hasegawa K, Fujiwara H, Doyama K, et al. Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy. Circulation 1993;88: 372-80.
12. 12. Takemura G, Fujiwara H. Mukoyama M, et al. Expression and distribution of atrial natriuretic peptide in human hypertrophic ventricle of hypertensive hearts and hearts with hypertrophic cardiomyopathy. Circulation 1991;83: 181-90.
13. 13. Report of the WHO/ISFC Task Force on the Definition and Classification of Cardiomyopathies. Br Heart J 1980;44:672-3.
14. 14. Nishimura RA, Tajik AJ. Quantitative hemodynamics by Doppler echocardiography: a noninvasive alternative to cardiac catheterization. Prog Cardiovasc Dis 1994;36:309-42.
15. 15. Schwammenthal E, Block M, Schwartzkopff B, et al. Prediction of the site and severity of obstruction in hypertrophic cardiomyopathy by color flow mapping and continuous wave Doppler echocardiography. J Am Coll Cardiol 1992;20:964-72.
16. 16. Fighali S, Krajcer Z, Edelman S, Leachman RD. Progression of hypertrophic cardiomyopathy into a hypokinetic left ventricle: high incidence in patients with midventricular obstruction. J Am Coll Cardiol 1987;9:288-94.
17. 17. Kono M, Yamauchi A, Tsuji T, et al. An immunoradiometric assay for brain natriuretic peptide in human plasma. Kaku Igaku 1993;13:2-7.
18. 18. Hama N, Nakao K, Mukoyama M, et al. Fundamental and clinical evaluation of "Shionoria ANP," human atrial natriuretic peptide IRMA kit. Clin Rep 1991;25:455-62.
19. 19. Stamm RB, Martin RP. Quantification of pressure gradients across stenotic valves by Doppler ultrasound. J Am Coll Cardiol 1983;2:707-18.
20. 20. Currie PJ, Seward JB, Reeder GS, et al. Continuous-wave Doppler echocardiographic assessment of severity of calcific aortic stenosis: a simultaneous Doppler-catheter correlation study in 100 adult patients. Circulation 1985;71:1162-9.
21. 21. Yoshibayashi M, Kamiya T, Saito Y, Matsuo H. Increased plasma levels of brain natriuretic peptide in hypertrophic cardiomyopathy. N Engl J Med 1993;329:433-4.
22. 22. Kono M, Horio T, Yokokawa K, Yasunari K. Ikeda M, Minami M, Kurihara N, Takeda T. Brain natriuretic peptide as a marker for hypertensive ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor. Am J Med 1995;98:257-65.
23. 23. Morita E, Yasue H, Yoshimura M, et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 1993;88:82-91.
24. 24. Hoshino T, Fujiwara H, Kawai C, Hamashima Y. Myocardial fiber diameter and regional distribution in the ventricular hearts and hearts with hypertrophic cardiomyopathy. Circulation 1983;67:1109-16.
25. 25. Tanaka M, Fujiwara H, Onodera T, Wu DJ, Hamashima Y, Kawai C. Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy. Br Heart J 1986;55:575-81.
26. 26. Kinnunen P, Vuolteenaho O, Uusimaa P, Ruskoaho H. Passive mechanical stretch releases atrial natriuretic peptide from rat ventricular myocardium. Circ Res 1992;70:1244-53.
27. 27. Brown LA, Nunez DJ, Wilkins MR. Differential regulation of natriuretic peptide receptor messenger RNAs during the development of cardiac hypertrophy in the rat. J Clin Invest 1993;92:2702-12.